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Figure 1. Speculative Models of GMAP-210 Function in Linking and Positioning Golgi Membranes
(A) The mammalian Golgi forms a pericentrosomal ribbon-like membrane system comprised of linked ministacks.
(B) Golgi-localized GMAP-210 may bind -tubulin complexes leading to the presence of short, stabilized microtubules on the Golgi ministacks.
These could be linked to adjacent ministacks by other Golgi-localized microtubule binding proteins (e.g., CLASP2, which binds and stabilizes
microtubule plus ends).
(C) Alternatively, GMAP-210 bound Golgi microtubules may facilitate capture of Golgi membranes by outgrowing centrosomal microtubule
plus ends and the subsequent engagement of dynein/dynactin complexes. Attachment factors may include CLASP2, CLIP-59, BICD2, Hook3,
p150Glued, golgin-84, TMF/ARA160, or others.
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GMAP-210 in place to maintain a central Golgi ribbon,
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Ubiquitylation provides a means of targeting substrateroles. A dramatic example is provided during cell divi-
proteins for degradation by the proteasome. Novelsion when Golgi membranes normally vesiculate and
findings in C. elegans (Hoppe et al., 2004, this issuedisperse. Failure of Golgi dispersal is associated with
of Cell ) establish that two ubiquitin-ligases team upsevere mitotic defects, indicating that Golgi fragmenta-
to multiubiquitylate the myosin chaperone UNC-45,tion is a necessary part of cell cycle progression (Colanzi
suggesting a novel link between regulated proteinet al., 2003). In this light, the mechanisms now being
degradation and myosin assembly.elucidated for positioning of the Golgi apparatus have
significance at many levels.
Selective protein degradation by the 26S proteasome
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destined for proteasome-mediated degradation are promoter. The fusion proteins displayed an overlapping
expression pattern that included body wall muscle cells,marked by the covalent attachment of ubiquitin, through
a sequence that involves an E1 ubiquitin-activating en- which also express UNC-45. Therefore, UFD-2, CHN-1,
and UNC-45 are all present at the crime scene. More-zyme, an E2 ubiquitin-conjugating enzyme, and an E3
ubiquitin-ligase (Pickart, 2004). This sequence can be over, a functional FLAG-tagged UNC-45 was ubiqui-
tylated in worm lysates, compatible with the in vitroiterated and multiubiquitylated proteins are preferred
substrates of the proteasome. In some cases, efficient activities of UFD-2 and CHN-1. The authors isolated a
deletion allele of chn-1, which displayed no obviousmultiubiquitylation requires a distinct ubiquitylation fac-
tor termed E4. S. cerevisiae UFD2, the first E4 to be morphological defects under standard growth condi-
tions. Importantly, however, several phenotypic mani-described, recognizes substrates bearing one to three
ubiquitin molecules and catalyzes addition of further festations caused by a temperature-sensitive allele of
unc-45 were significantly suppressed by the absenceubiquitin moieties in the presence of E1, E2, and E3
enzymes, thus yielding multiubiquitylated substrates of chn-1. In contrast, analogous phenotypes caused by
mutations in other body wall muscle components were(Koegl et al., 1999). UFD2 defines a protein family that
bears a U-box thought to be structurally related to the not suppressed, indicating specificity of the genetic in-
teraction between unc-45 and chn-1. Whether a similarRING finger found in many E3 ubiquitin-ligases (Aravind
and Koonin, 2000). Human CHIP (carboxyl-terminus of interaction exists between unc-45 and ufd-2, and
whether the combined absence of ufd-2 and chn-1Hsc70 interacting protein) is another U-box-containing
protein that can act as an E4. CHIP promotes multiubiq- would potentiate these effects, awaits isolation of an
ufd-2 mutant allele. In a converse set of experiments,uitylation of the unfolded membrane protein Pael-R by
the E3 enzyme Parkin, a protein affected in familial Par- the authors established that overexpression of UNC-45
in body wall muscle cells, while being of no conse-kinson’s disease (Imai et al., 2002). This finding notwith-
standing, the nature of in vivo substrates for CHIP or quence in a wild-type background, resulted in dramatic
muscle defects in the chn-1 mutant background. To-other E4 remained poorly characterized. Exciting find-
ings by Hoppe and colleagues published in this issue gether, these findings indicate that CHN-1 is a negative
regulator of UNC-45 in muscle cells, most likely via itsof Cell establish that UFD-2 and CHN-1, the C. elegans
homologs of UFD2 and CHIP, act in concert to multiubiq- ability to promote multiubiquitylation in concert with
UFD-2. Whereas the biological function of this modifica-uitylate the myosin chaperone UNC-45, suggesting that
selective protein degradation contributes to proper my- tion remains to be determined experimentally, an ap-
pealing hypothesis is that UNC-45 multiubiquitylationosin assembly (Hoppe et al., 2004).
The authors first characterized the biochemical activ- promotes its degradation by the proteasome. In this
view, multiubiquitylation is crucial for proper myosin as-ity of UFD-2, as well as that of CHN-1, which they identi-
fied in a yeast two-hybrid assay as a binding partner sembly by setting the levels of UNC-45 available for
aiding myosin folding.of UFD-2. In the presence of appropriate E1 and E2
enzymes, both UFD-2 and CHN-1 underwent self-ubiq- In the future, it will be interesting to elucidate the
mechanism by which UFD-2/CHN-1 ensures multiubiq-uitylation, as is characteristic of ubiquitin-ligases. Next,
the authors made the key finding that UFD-2 and CHN-1 uitylation of UNC-45. Perhaps complex formation stabi-
lizes conformations of UFD-2 and CHN-1 that allow opti-both interact with purified UNC-45 in vitro. UNC-45 is a
member of the UCS (UNC-45/CRO1/She4p) family of mal ubiquitin ligation. Alternatively, such a complex may
be necessary for ubiquitin-ubiquitin linkages that en-proteins that are required for myosin assembly (Hutaga-
lung et al., 2002). UNC-45 helps ensure that muscle gage different lysine residues on the ubiquitin polypep-
tide than those utilized for monoubiquitinylation, as hasmyosin is properly folded through a dual mechanism:
by exerting chaperone activity directly on the myosin been suggested in the case of S. cerevisae UFD2 (Koegl
et al., 1999). Regardless of the mechanism, the findingshead and by acting as a cochaperone for the heat-shock
protein Hsp90 (Barral et al., 2002). As might be expected of Hoppe and colleagues (2004) reveal an unsuspected
plasticity among E4 enzymes. Whereas S. cerevisiaefrom such a role, unc-45 mutant animals exhibit severely
disorganized myofibrils and dramatically decreased UFD2 and human CHIP can each individually exert E4
activity, formation of an UFD-2/CHN-1 heterooligomerbody movements. What is the consequence of the physi-
cal interactions detected between UNC-45 and UFD-2 is essential for UNC-45 multiubiquitylation in C. elegans.
Interestingly, homodimerization is needed for CHIP ac-or CHN-1? Importantly, Hoppe and collaborators (2004)
found that UNC-45 is a substrate for UFD-2- and CHN-1- tivity (Nikolay et al., 2004), raising the possibility that a
CHIP homooligomer functions in an analogous mannerdependent ubiquitylation. When either UFD-2 or CHN-1
was present alone, most of the UNC-45 conjugates con- to a UFD-2/CHN-1 heterooligomer. Hoppe and collabo-
rators (2004) speculate that formation of such hetero-tained only one to three ubiquitin moieties, whereas
simultaneous addition of UFD-2 and CHN-1 dramatically oligomers may offer added plasticity for metazoan or-
ganisms, because degradation of specific substratesenhanced multiubiquitylation of UNC-45. These findings
indicate that C. elegans UFD-2 and CHN-1 merely act could be induced by developmentally regulated coex-
pression of a combination of appropriate E3 enzymes.as E3 ubiquitin-ligases on their own and suggest a novel
mechanism in which E4 activity is achieved by formation A careful balance between molecular chaperones,
which help fold proteins, and enzymes of the ubiquityla-of a heterooligomeric complex comprised of two E3 en-
zymes. tion pathway, which promote their degradation, ensures
adequate protein homeostasis in eukaryotic cells. CHIPWhat is the in vivo relevance of the interactions ob-
served in vitro? Hoppe and colleagues (2004) analyzed is central to this balance in neuronal cells, not only be-
cause it enhances the ability of Parkin to multiubiqui-the distribution of GFP driven by the ufd-2 or the chn-1
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tylate Pael-R, but also because it leads to dissociation Gene targeting in mice is a powerful tool for uncovering
the physiological roles of proteins and is increasinglyof Hsp70 from Parkin and Pael-R, thus further driving
being used for preclinical validation of potential newPael-R degradation (Imai et al., 2002). It will be interest-
drug targets (Harris, 2001). Different experimental strate-ing to determine whether the UFD-2/CHN-1 complex
gies of gene targeting can, however, give rise to verymay similarly lead to dissociation of Hsp90 from UNC-
distinct phenotypes. The commonest pitfalls include45, something that could contribute to rendering it more
“neighborhood” phenotypic effects caused by retentionprone to degradation. UNC-45 proteins are conserved
of selection cassettes in the targeted locus, multipleacross metazoan evolution (Hutagalung et al., 2002) and
gene inactivation, and creation of truncated biologicallyUFD2, as well as CHIP, are abundantly expressed in
active gene products, any of which can lead to “off-human muscle cells (Ballinger et al., 1999; Mahoney et
target” phenotypes. It is also becoming increasinglyal., 2002). Therefore, the regulation of myosin assembly
clear that “knocking out” (KO) a gene is not the equiva-via multiubiquitylation of UNC-45 uncovered in C. ele-
lent of “knocking in” (KI) an inactivating point mutationgans should have important implication for understand-
or an otherwise disabled full-length version of the gene.ing myosin assembly during physiological and patholog-
A prime example highlighting how different gene inacti-ical conditions in humans. Moreover, since other UCS
vation strategies can lead to strikingly different pheno-proteins interact with unconventional myosin, increased
types is published in this issue of Cell (Patrucco et al.,understanding of the mechanisms by which multiubiqui-
2004). In this study, Hirsch’s group inactivated p110,tylation regulates their function will undoubtedly shed
a member of the phosphoinositide 3-kinase (PI3K) genelight on other myosin-dependent processes such as cell
family, by knocking in a kinase-dead version into themotility and cytokinesis.
endogenous p110 gene locus, and observed a very
unexpected result.
PI3Ks generate lipid signals downstream of receptorsPierre Go¨nczy
and are considered to be good targets for pharmacologi-ISREC (Swiss Institute for Experimental Cancer
cal intervention in diseases associated with deregulatedResearch)
PI3K activity, such as cancer, inflammation, and diabe-155, ch. des Boveresses
tes. There are several isoforms of PI3K linked to differentCH-1066 Epalinges/Lausanne
receptor systems and with apparently discrete functionsSwitzerland
in cells and in the organism (reviewed in Vanhaese-
broeck et al., 2001). These include the p110, , and 
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phenotype of the p110 KO mouse, published by three
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independent groups in Science a few years ago (DekkerH.F. (2002). Science 295, 669–671.
and Segal, 2000), seemed straightforward at first. These
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p110KO mice were apparently healthy but had a damp-Epstein, H.F., and Baumeister, R. (2004). 118, this issue, 337–349.
ened immune response when challenged with inflamma-
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flammatory migration of macrophages and reduced
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These studies caused quite a stir and put p110 on the
Koegl, M., Hoppe, T., Schlenker, S., Ulrich, H.D., Mayer, T.U., and top of the wish list of many pharmaceutical companies
Jentsch, S. (1999). Cell 96, 635–644.
in their quest for new anti-inflammatory drug targets.
Mahoney, J.A., Odin, J.A., White, S.M., Shaffer, D., Koff, A., Casciola- This enthusiasm was greatly tempered by a follow-up
Rosen, L., and Rosen, A. (2002). Biochem. J. 361, 587–595. report that the p110 KO mice developed colon cancer
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would certainly be an undesirable side effect of p110
Pickart, C.M. (2004). Cell 116, 181–190. inhibitors. However, independently created p110 KO
mouse lines did not develop cancer (Barbier et al., 2001).
The exact reason for the isolated case of a cancer phe-
notype is still not clear (Sasaki et al., 2003) but is possibly
Gene Targeting: Attention to Detail related to mutations acquired in the ES cells during
culture and gene targeting. This finding put the minds of
p110 drug developers at rest, but only for a little while.
Further alarm bells went off when it became clear
that the p110 KO mice, apart from an immunological
When it comes to silencing genes in mice, not all ap- phenotype, also had a cardiac defect, namely increased
proaches are equal. An example published in this issue contractility (Crackower et al., 2002). PI3K action has
of Cell (Patrucco et al., 2004) suggests that caution been implicated in cardiac function and several GPCR-
should be used when validating potential drug targets signaling pathways, including those triggered by adren-
ergic receptors, have important functions in the heartby genetic disruption
